Elemer Piros
Stock Analyst at Lucid Capital
(0.07)
# 4,306
Out of 4,345 analysts
390
Total ratings
35.4%
Success rate
-8%
Average return
Main Sectors:
Stocks Rated by Elemer Piros
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXP NRx Pharmaceuticals | Initiated Coverage: Buy | $49 | $4.28 | +1,044.86% | 1 | May 13, 2026 | |
| XOMA XOMA Royalty | Downgraded: Hold | $66 → $39 | $41.74 | -6.56% | 2 | Apr 27, 2026 | |
| PASG Passage Bio | Downgraded: Hold | $68 → $9 | $5.52 | +63.04% | 3 | Apr 20, 2026 | |
| NGEN NervGen Pharma | Initiated Coverage: Buy | $18 | $2.07 | +769.57% | 1 | Apr 15, 2026 | |
| OCGN Ocugen | Maintained: Buy | $15 → $22 | $1.38 | +1,494.20% | 2 | Mar 11, 2026 | |
| INMB INmune Bio | Upgraded: Buy | $2 → $9 | $1.41 | +540.57% | 4 | Mar 11, 2026 | |
| QNCX Quince Therapeutics | Downgraded: Sell | n/a | $1.15 | - | 3 | Jan 30, 2026 | |
| MNOV MediciNova | Initiated Coverage: Buy | $11 | $1.33 | +727.07% | 1 | Jan 5, 2026 | |
| VTGN Vistagen Therapeutics | Downgraded: Hold | $19 → $1 | $0.6241 | +60.23% | 2 | Dec 17, 2025 | |
| SWX: NWRN Newron Pharmaceuticals S.p.A. | Initiated Coverage: Buy | n/a | $14.18 | - | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $81 → $2.3 | $5.40 | -57.41% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2 → $8 | $1.50 | +433.33% | 5 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.77 | +319.29% | 7 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $2.54 | +116.54% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $1.69 | +669.23% | 1 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.47 | +444.22% | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.31 | - | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $9.89 | +405.56% | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $57 → $106 | $4.43 | +2,292.78% | 5 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $12 | $4.32 | +177.78% | 9 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 → $28 | $21.47 | +30.41% | 7 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $71 | $64.55 | +9.99% | 7 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 → $120 | $7.07 | +1,597.31% | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.29 | n/a | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $36 | $22.36 | n/a | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $9 | $11.85 | n/a | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $1.12 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $3.23 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $43 → $5.5 | $20.44 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.16 | n/a | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $0.75 | $9.81 | n/a | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $2.01 | n/a | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $1.19 | n/a | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $455 | $6.81 | n/a | 1 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $28 | $23.52 | n/a | 8 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $1.36 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $1.24 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.6929 | n/a | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 → $13 | $6.69 | n/a | 7 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $24 | $6.10 | n/a | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.22 → $1.79 | $7.82 | n/a | 41 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $77 → $45 | $7.66 | n/a | 5 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.33 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $8 | $0.075 | n/a | 2 | Dec 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.66 | n/a | 16 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $29 → $2 | $5.69 | n/a | 33 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $94 | $25.17 | n/a | 16 | Jul 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 | $78.99 | n/a | 24 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $1.71 | n/a | 17 | Jun 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $67 | $306.63 | n/a | 8 | Jun 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.6375 | n/a | 1 | Jun 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $29.48 | n/a | 14 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $0.62 | n/a | 11 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $24 | $15.54 | n/a | 26 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $8.54 | n/a | 16 | Mar 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $109.88 | n/a | 16 | May 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $11.07 | n/a | 16 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $116.14 | n/a | 3 | Mar 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.70 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $81.76 | n/a | 1 | Feb 15, 2012 |
NRx Pharmaceuticals
May 13, 2026
Initiated Coverage: Buy
Price Target: $49
Current: $4.28
Upside: +1,044.86%
XOMA Royalty
Apr 27, 2026
Downgraded: Hold
Price Target: $66 → $39
Current: $41.74
Upside: -6.56%
Passage Bio
Apr 20, 2026
Downgraded: Hold
Price Target: $68 → $9
Current: $5.52
Upside: +63.04%
NervGen Pharma
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $2.07
Upside: +769.57%
Ocugen
Mar 11, 2026
Maintained: Buy
Price Target: $15 → $22
Current: $1.38
Upside: +1,494.20%
INmune Bio
Mar 11, 2026
Upgraded: Buy
Price Target: $2 → $9
Current: $1.41
Upside: +540.57%
Quince Therapeutics
Jan 30, 2026
Downgraded: Sell
Price Target: n/a
Current: $1.15
Upside: -
MediciNova
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $1.33
Upside: +727.07%
Vistagen Therapeutics
Dec 17, 2025
Downgraded: Hold
Price Target: $19 → $1
Current: $0.6241
Upside: +60.23%
Newron Pharmaceuticals S.p.A.
Dec 11, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $14.18
Upside: -
Oct 21, 2025
Downgraded: Hold
Price Target: $81 → $2.3
Current: $5.40
Upside: -57.41%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $2 → $8
Current: $1.50
Upside: +433.33%
Sep 22, 2025
Reiterated: Buy
Price Target: $20
Current: $4.77
Upside: +319.29%
Aug 13, 2025
Initiated Coverage: Buy
Price Target: $5.5
Current: $2.54
Upside: +116.54%
Jul 31, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $1.69
Upside: +669.23%
Jul 22, 2025
Initiated Coverage: Buy
Price Target: $8
Current: $1.47
Upside: +444.22%
Jul 15, 2025
Maintained: Buy
Price Target: n/a
Current: $1.31
Upside: -
Jun 9, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $9.89
Upside: +405.56%
Jun 6, 2025
Initiated Coverage: Buy
Price Target: $57 → $106
Current: $4.43
Upside: +2,292.78%
Jun 6, 2025
Initiated Coverage: Buy
Price Target: $7 → $12
Current: $4.32
Upside: +177.78%
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $100 → $28
Current: $21.47
Upside: +30.41%
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $50 → $71
Current: $64.55
Upside: +9.99%
Jun 4, 2025
Initiated Coverage: Buy
Price Target: $5 → $120
Current: $7.07
Upside: +1,597.31%
Feb 20, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $1.29
Upside: n/a
Feb 7, 2025
Maintained: Buy
Price Target: $42 → $36
Current: $22.36
Upside: n/a
Jan 27, 2025
Maintained: Buy
Price Target: $30 → $9
Current: $11.85
Upside: n/a
Dec 11, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $1.12
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $3.23
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: $43 → $5.5
Current: $20.44
Upside: n/a
Sep 30, 2024
Initiated Coverage: Buy
Price Target: $17
Current: $1.16
Upside: n/a
Sep 4, 2024
Downgraded: Hold
Price Target: $22 → $0.75
Current: $9.81
Upside: n/a
Jul 2, 2024
Maintained: Buy
Price Target: $67
Current: $2.01
Upside: n/a
Jun 13, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $1.19
Upside: n/a
Jun 12, 2024
Initiated Coverage: Buy
Price Target: $455
Current: $6.81
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $21 → $28
Current: $23.52
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $14
Current: $1.36
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $68
Current: $1.24
Upside: n/a
May 31, 2023
Initiated Coverage: Buy
Price Target: $40
Current: $0.6929
Upside: n/a
Mar 8, 2023
Initiated Coverage: Buy
Price Target: $11 → $13
Current: $6.69
Upside: n/a
Oct 27, 2021
Reiterated: Buy
Price Target: $32 → $24
Current: $6.10
Upside: n/a
Mar 15, 2021
Maintained: Hold
Price Target: $1.22 → $1.79
Current: $7.82
Upside: n/a
Mar 2, 2021
Maintained: Sell
Price Target: $77 → $45
Current: $7.66
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $9
Current: $2.33
Upside: n/a
Dec 1, 2020
Maintained: Buy
Price Target: $14 → $8
Current: $0.075
Upside: n/a
Sep 10, 2019
Reiterated: Buy
Price Target: $23
Current: $14.66
Upside: n/a
Aug 12, 2019
Downgraded: Hold
Price Target: $29 → $2
Current: $5.69
Upside: n/a
Jul 8, 2019
Reiterated: Buy
Price Target: $81 → $94
Current: $25.17
Upside: n/a
Jun 27, 2019
Downgraded: Hold
Price Target: $24
Current: $78.99
Upside: n/a
Jun 25, 2019
Reiterated: Buy
Price Target: $35 → $33
Current: $1.71
Upside: n/a
Jun 24, 2019
Maintained: Buy
Price Target: $34 → $67
Current: $306.63
Upside: n/a
Jun 20, 2019
Initiated Coverage: Buy
Price Target: $7
Current: $0.6375
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $7
Current: $29.48
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $59
Current: $0.62
Upside: n/a
Mar 19, 2019
Reiterated: Buy
Price Target: $18 → $24
Current: $15.54
Upside: n/a
Mar 7, 2019
Reiterated: Buy
Price Target: $24
Current: $8.54
Upside: n/a
May 4, 2018
Maintained: Hold
Price Target: n/a
Current: $109.88
Upside: n/a
Mar 1, 2018
Maintained: Hold
Price Target: $19
Current: $11.07
Upside: n/a
Mar 23, 2016
Reiterated: Buy
Price Target: $7
Current: $116.14
Upside: n/a
Mar 9, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $2.70
Upside: n/a
Feb 15, 2012
Maintained: Hold
Price Target: n/a
Current: $81.76
Upside: n/a